Factors that influence patient preferences for prostate cancer management options: a systematic review

被引:44
|
作者
Showalter, Timothy N. [1 ]
Mishra, Mark V. [2 ]
Bridges, John F. P. [3 ]
机构
[1] Univ Virginia, Dept Radiat Oncol, Sch Med, Charlottesville, VA 22908 USA
[2] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Care Policy & Management, Baltimore, MD USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2015年 / 9卷
关键词
prostate cancer; treatment; decision making; preferences; patient; TREATMENT DECISION-MAKING; TREATMENT CHOICE; BREAST-CANCER; MEN; RISK; SURVEILLANCE; SATISFACTION; PERSPECTIVE; OUTCOMES; QUALITY;
D O I
10.2147/PPA.S83333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We performed a systematic review to evaluate evidence regarding factors that influence patient preferences for management options for localized prostate cancer. Methods: We followed a prespecified search protocol (PROSPERO identifier CRD42014009173) to identify studies that evaluated patient preferences for prostate cancer management options for localized prostate cancer. We queried PubMed, the Cochrane Database of Systematic Reviews, Embase, Cumulative Index to Nursing & Allied Health Literature (CINAHL) Plus, and Econ-Lit databases. Two separate reviewers completed the article selection process and review, including coding of study characteristics. Study quality was scored according to the PREFS checklist, which consists of five criteria: Purpose, Respondents, Explanation, Findings, and Significance. Reviewers summarized the primary findings of each article included in the analysis. Results: Of the 606 citations identified in the literature search, there were a total of 21 articles that met all selection criteria, reporting results for a total of 4,131 subjects. Themes identified in the studies included: the importance of patient perceptions of treatment efficacy and side effects; the influence of physician recommendations on patient decision-making; and the prioritization of concerns regarding treatment side effects among those men who prefer radiation therapy or active surveillance. The articles had an average PREFS score of 3.4 (standard deviation [SD] 1.0), which is similar to a recent study for breast cancer treatment preferences. Conclusion: This systematic review of factors that influence patient preferences for prostate cancer management options identified a small, but high quality, group of articles that satisfied the selection criteria. The available evidence suggests that interventions aimed at informing patients regarding the comparative effectiveness of prostate cancer management alternatives should include the influence of physician recommendations and family members' desires on patient decision-making.
引用
收藏
页码:899 / 911
页数:12
相关论文
共 50 条
  • [11] Men's perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review
    Brown, Amy
    Yim, Jackie
    Jones, Scott
    Tan, Alex
    Callander, Emily
    Watt, Kerrianne
    Lourenco, Richard De Abreu
    Pain, Tilley
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 38 : 28 - 42
  • [12] Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options
    Egerdie, Blair
    Saad, Fred
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (02): : 129 - 135
  • [13] Smoking and Prostate Cancer: A Systematic Review
    De Nunzio, Cosimo
    Andriole, Gerald L.
    Thompson, Ian M., Jr.
    Freedland, Stephen J.
    EUROPEAN UROLOGY FOCUS, 2015, 1 (01): : 28 - 38
  • [14] Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
    A Lloyd
    D Penson
    S Dewilde
    L Kleinman
    Prostate Cancer and Prostatic Diseases, 2008, 11 : 153 - 159
  • [15] Differences between physician and patient preferences for cancer treatments: a systematic review
    Zhang, Mengqian
    He, Xiaoning
    Wu, Jing
    Xie, Feng
    BMC CANCER, 2023, 23 (01)
  • [16] The lived experience of active surveillance for prostate cancer: a systematic review and meta-synthesis
    Briggs, Russell J.
    Dunn, Jeff
    Chambers, Suzanne K.
    Jakimowicz, Samantha
    Green, Anna
    Heneka, Nicole
    JOURNAL OF CANCER SURVIVORSHIP, 2025,
  • [17] Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
    Lloyd, A.
    Penson, D.
    Dewilde, S.
    Kleinman, L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2008, 11 (02) : 153 - 159
  • [18] Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
    Beyer, Katharina
    Moris, Lisa
    Lardas, Michael
    Haire, Anna
    Barletta, Francesco
    Scuderi, Simone
    Molnar, Megan
    Herrera, Ronald
    Rauf, Abdul
    Campi, Riccardo
    Greco, Isabella
    Shiranov, Kirill
    Dabestani, Saeed
    van den Broeck, Thomas
    Arun, Sujenthiran
    Gacci, Mauro
    Gandaglia, Giorgio
    Omar, Muhammad Imran
    MacLennan, Steven
    Roobol, Monique J.
    Farahmand, Bahman
    Vradi, Eleni
    Devecseri, Zsuzsanna
    Asiimwe, Alex
    Zong, Jihong
    Maclennan, Sara J.
    Collette, Laurence
    NDow, James
    Briganti, Alberto
    Bjartell, Anders
    Van Hemelrijck, Mieke
    BMJ OPEN, 2022, 12 (04):
  • [19] Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
    Vernooij, Robin W. M.
    Lytvyn, Lyubov
    Pardo-Hernandez, Hector
    Albarqouni, Loai
    Canelo-Aybar, Carlos
    Campbell, Karen
    Agoritsas, Thomas
    BMJ OPEN, 2018, 8 (09):
  • [20] Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis
    Darcey, Ellie
    Boyle, Terry
    CANCER TREATMENT REVIEWS, 2018, 70 : 30 - 40